• Mashup Score: 0

    Introduction We aimed to compare the proportions of patients with newly diagnosed psoriatic arthritis (PsA) and rheumatoid arthritis (RA) remaining on methotrexate (regardless of other disease-modifying antirheumatic drug (DMARD)-changes), and proportions not having started another DMARD (regardless of methotrexate discontinuation), within 2 years of starting methotrexate, as well as methotrexate…

    Tweet Tweets with this article
    • Swedish registry review of #MTX initiation in early #PsA vs #RA (n 3642each). 2 years after MTX start, 71% of PsA vs 76% of patients with RA remained on MTX & the majority (66%/60%) had not started another DMARD, or a biologic (77%/74%) https://t.co/nTJO04sn65 https://t.co/gLjKzj2c74

  • Mashup Score: 0

    Objective To investigate sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis. Methods Patients who had an inadequate response to methotrexate (MTX) with or without biological disease-modifying antirheumatic drugs were randomly divided into two groups at baseline, and tofacitinib treatment in combination with MTX was administered to both groups….

    Tweet Tweets with this article
    • open-label randomised study in #RA patients and inadequate #MTX response receiving #tofacitinib addon -48/113 in remission at week 52 then stop either tofa or MTX At week 104: 7/24 with tofa stop remain remission 10/20 with MTX stop remain in remission https://t.co/AgI6oUyWnn https://t.co/qAITxuB6T2

  • Mashup Score: 5

    The European Alliance of Associations for Rheumatology recently defined difficult to treat (D2T) rheumatoid arthritis (RA) and provided points to consider in its management. This review summarises the key concepts of D2T-RA that underpinned this recent guidance. D2T-RA is primarily characterised by failure of at least two different mechanism of action biologic/targeted synthetic disease-modifying…

    Tweet Tweets with this article
    • Difficult-to-treat #Rheumatoid arthritis Evaluate ➡️ Presence or absence of inflammation ➡️Mimics +/- coexisting pathology ➡️Comorbidities ➡️Non adherence 👉🏼https://t.co/RHFZ1QueVx Via @ARD_BMJ via Prof Maya Buch #BSR23 https://t.co/mCWAIzDCi2

  • Mashup Score: 0

    The European Alliance of Associations for Rheumatology recently defined difficult to treat (D2T) rheumatoid arthritis (RA) and provided points to consider in its management. This review summarises the key concepts of D2T-RA that underpinned this recent guidance. D2T-RA is primarily characterised by failure of at least two different mechanism of action biologic/targeted synthetic disease-modifying…

    Tweet Tweets with this article
    • Difficult-to-treat #Rheumatoid arthritis Evaluate ➡️ Presence or absence of inflammation ➡️Mimics +/- coexisting pathology ➡️Comorbidities ➡️Non adherence 👉🏼https://t.co/RHFZ1QueVx Via @ARD_BMJ via Prof Maya Buch #BSR23 https://t.co/ipgK0PAG4i